Literature DB >> 10665821

Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.

A S Undie1, A C Berki, K Beardsley.   

Abstract

We determined the relative effects of chemical receptor inactivation on dopaminergic signaling through adenylate cyclase and phospholipase C pathways and evaluated the behavioral implications of such receptor manipulations. Groups of rats were given intraperitoneal injections of 10 mg/kg N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), a reagent that differentially inactivates neurotransmitter receptors. Control and treated animals were used to assess dopaminergic-mediated behaviors or brain tissues were prepared from the animals and used to assay D1-like receptor binding and agonist-stimulated second messenger formation. EEDQ decreased by 75% the number of D1-like binding sites and completely abolished dopamine-stimulated cyclic AMP formation in striatal membranes. Conversely, dopamine-stimulated phosphoinositide hydrolysis was insensitive to inactivation by EEDQ as examined over different durations of EEDQ treatment, in different brain regions, or with different concentrations of the D1-like receptor agonist SKF38393. EEDQ-pretreated animals lost their stereotypic response to apomorphine but showed increased vacuous jaw movements in response to apomorphine or SKF38393. Basal catalepsy was increased and SCH23390 was unable to further enhance catalepsy beyond the basal levels in the lesioned animals. In naive animals, SCH23390 catalepsy was reversed by apomorphine, and apomorphine stereotypy was reversed by SCH23390. Taken together, the present results imply that the dopamine-sensitive phospholipase C system mediates a subset of dopaminergic behaviors, notably vacuous jaw movements, in contrast to stereotypy and catalepsy which appear to be respectively mediated through stimulation and inhibition of the adenylate cyclase-coupled dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10665821     DOI: 10.1016/s0028-3908(99)00106-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

Review 2.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.

Authors:  Rajeev I Desai; John L Neumeyer; Carol A Paronis; Phong Nguyen; Jack Bergman
Journal:  Eur J Pharmacol       Date:  2006-12-01       Impact factor: 4.432

4.  Dopamine D1-class receptors selectively modulate a slowly inactivating potassium current in rat medial prefrontal cortex pyramidal neurons.

Authors:  Yan Dong; Francis J White
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

Review 5.  Rhes: a GTP-binding protein integral to striatal physiology and pathology.

Authors:  Laura M Harrison
Journal:  Cell Mol Neurobiol       Date:  2012-03-27       Impact factor: 5.046

6.  Molecular cloning and characterization of crustacean type-one dopamine receptors: D1alphaPan and D1betaPan.

Authors:  Merry C Clark; Deborah J Baro
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2006-01-19       Impact factor: 2.231

7.  D5 dopamine receptors are required for dopaminergic activation of phospholipase C.

Authors:  Asha Sahu; Kimberly R Tyeryar; Habiba O Vongtau; David R Sibley; Ashiwel S Undieh
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

8.  Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine.

Authors:  Takato Hiranita; Paul L Soto; Gianluigi Tanda; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2009-11-05       Impact factor: 4.030

Review 9.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

10.  D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice.

Authors:  Ivan O Medvedev; Amy J Ramsey; Shababa T Masoud; Marie Kristel Bermejo; Nikhil Urs; Tatyana D Sotnikova; Jean-Martin Beaulieu; Raul R Gainetdinov; Ali Salahpour
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.